Cargando…

A Fixed-Dose Combination, QXOH/Levobupivacaine, Produces Long-Acting Local Anesthesia in Rats Without Additional Toxicity

QXOH, a QX314 derivative with longer duration and lesser local toxicity, is a novel local anesthetic in preclinical drug development. Previous studies demonstrated that bupivacaine can prolong the effects of QX314. So, we attempted to combine QXOH with levobupivacaine to shorten the onset time and l...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Qinqin, Zhang, Yujun, Lv, Rong, Gong, Deying, Ke, Bowen, Yang, Jun, Tang, Lei, Zhang, Wensheng, Zhu, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443723/
https://www.ncbi.nlm.nih.gov/pubmed/30971919
http://dx.doi.org/10.3389/fphar.2019.00243
_version_ 1783407888444686336
author Yin, Qinqin
Zhang, Yujun
Lv, Rong
Gong, Deying
Ke, Bowen
Yang, Jun
Tang, Lei
Zhang, Wensheng
Zhu, Tao
author_facet Yin, Qinqin
Zhang, Yujun
Lv, Rong
Gong, Deying
Ke, Bowen
Yang, Jun
Tang, Lei
Zhang, Wensheng
Zhu, Tao
author_sort Yin, Qinqin
collection PubMed
description QXOH, a QX314 derivative with longer duration and lesser local toxicity, is a novel local anesthetic in preclinical drug development. Previous studies demonstrated that bupivacaine can prolong the effects of QX314. So, we attempted to combine QXOH with levobupivacaine to shorten the onset time and lengthen the duration. In this study, we investigated the efficacy, local and systemic toxicity in rats. In subcutaneous infiltration anesthesia, the inhibition of cutaneous trunci muscle reflex for QXOH-LB was greater than QXOH and levobupivacaine in the first 8 h (QXOH-LB vs. QXOH, P = 0.004; QXOH-LB vs. LB, P = 0.004). The completely recovery time for QXOH-LB (17.5 ± 2.5 h) was significantly longer than levobupivacaine (9.0 ± 1.3 h, P = 0.034) and QXOH (9.8 ± 0.9 h, P = 0.049). In sciatic nerve block, QXOH-LB produced a rapid onset time, which was obviously shorter than QXOH. For sensory, the time to recovery for QXOH-LB was 17.3 ± 2.6 h, which was statistically longer than 6.0 ± 1.8 h for QXOH (P = 0.027), and 4 h for levobupivacaine (P = 0.001). Meanwhile, the time to motor recovery for QXOH-LB was 7.9 ± 2.8 h, significantly longer than 4 h for levobupivacaine (P = 0.003) but similar to 6.0 ± 1.7 h for QXOH (P = 0.061). In local toxicity, there was no significant difference of histological score regarding muscle and sciatic nerve in QXOH-LB, QXOH, levobupivacaine and saline (P < 0.01). In the combination, the interaction index of LD(50) was 1.39, indicating antagonistic interaction between QXOH and levobupivacaine in terms of systemic toxicity. In this study, we demonstrated that QXOH-LB produced cutaneous anesthesia which was 2-fold greater than that produced by QXOH or LB alone, and elicited sciatic nerve block with a potency that was 5- and 3-fold that of LB and QXOH, respectively. Local tissue inflammation by QXOH-LB was mild, similar to that induced by LB. This fixed-dose combination led to an antagonistic interaction between QXOH and LB in terms of systemic toxicity. These results suggested that QXOH-LB induced a long-lasting local anesthesia, likely, avoiding clinically important local and systemic toxicities.
format Online
Article
Text
id pubmed-6443723
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-64437232019-04-10 A Fixed-Dose Combination, QXOH/Levobupivacaine, Produces Long-Acting Local Anesthesia in Rats Without Additional Toxicity Yin, Qinqin Zhang, Yujun Lv, Rong Gong, Deying Ke, Bowen Yang, Jun Tang, Lei Zhang, Wensheng Zhu, Tao Front Pharmacol Pharmacology QXOH, a QX314 derivative with longer duration and lesser local toxicity, is a novel local anesthetic in preclinical drug development. Previous studies demonstrated that bupivacaine can prolong the effects of QX314. So, we attempted to combine QXOH with levobupivacaine to shorten the onset time and lengthen the duration. In this study, we investigated the efficacy, local and systemic toxicity in rats. In subcutaneous infiltration anesthesia, the inhibition of cutaneous trunci muscle reflex for QXOH-LB was greater than QXOH and levobupivacaine in the first 8 h (QXOH-LB vs. QXOH, P = 0.004; QXOH-LB vs. LB, P = 0.004). The completely recovery time for QXOH-LB (17.5 ± 2.5 h) was significantly longer than levobupivacaine (9.0 ± 1.3 h, P = 0.034) and QXOH (9.8 ± 0.9 h, P = 0.049). In sciatic nerve block, QXOH-LB produced a rapid onset time, which was obviously shorter than QXOH. For sensory, the time to recovery for QXOH-LB was 17.3 ± 2.6 h, which was statistically longer than 6.0 ± 1.8 h for QXOH (P = 0.027), and 4 h for levobupivacaine (P = 0.001). Meanwhile, the time to motor recovery for QXOH-LB was 7.9 ± 2.8 h, significantly longer than 4 h for levobupivacaine (P = 0.003) but similar to 6.0 ± 1.7 h for QXOH (P = 0.061). In local toxicity, there was no significant difference of histological score regarding muscle and sciatic nerve in QXOH-LB, QXOH, levobupivacaine and saline (P < 0.01). In the combination, the interaction index of LD(50) was 1.39, indicating antagonistic interaction between QXOH and levobupivacaine in terms of systemic toxicity. In this study, we demonstrated that QXOH-LB produced cutaneous anesthesia which was 2-fold greater than that produced by QXOH or LB alone, and elicited sciatic nerve block with a potency that was 5- and 3-fold that of LB and QXOH, respectively. Local tissue inflammation by QXOH-LB was mild, similar to that induced by LB. This fixed-dose combination led to an antagonistic interaction between QXOH and LB in terms of systemic toxicity. These results suggested that QXOH-LB induced a long-lasting local anesthesia, likely, avoiding clinically important local and systemic toxicities. Frontiers Media S.A. 2019-03-26 /pmc/articles/PMC6443723/ /pubmed/30971919 http://dx.doi.org/10.3389/fphar.2019.00243 Text en Copyright © 2019 Yin, Zhang, Lv, Gong, Ke, Yang, Tang, Zhang and Zhu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Yin, Qinqin
Zhang, Yujun
Lv, Rong
Gong, Deying
Ke, Bowen
Yang, Jun
Tang, Lei
Zhang, Wensheng
Zhu, Tao
A Fixed-Dose Combination, QXOH/Levobupivacaine, Produces Long-Acting Local Anesthesia in Rats Without Additional Toxicity
title A Fixed-Dose Combination, QXOH/Levobupivacaine, Produces Long-Acting Local Anesthesia in Rats Without Additional Toxicity
title_full A Fixed-Dose Combination, QXOH/Levobupivacaine, Produces Long-Acting Local Anesthesia in Rats Without Additional Toxicity
title_fullStr A Fixed-Dose Combination, QXOH/Levobupivacaine, Produces Long-Acting Local Anesthesia in Rats Without Additional Toxicity
title_full_unstemmed A Fixed-Dose Combination, QXOH/Levobupivacaine, Produces Long-Acting Local Anesthesia in Rats Without Additional Toxicity
title_short A Fixed-Dose Combination, QXOH/Levobupivacaine, Produces Long-Acting Local Anesthesia in Rats Without Additional Toxicity
title_sort fixed-dose combination, qxoh/levobupivacaine, produces long-acting local anesthesia in rats without additional toxicity
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443723/
https://www.ncbi.nlm.nih.gov/pubmed/30971919
http://dx.doi.org/10.3389/fphar.2019.00243
work_keys_str_mv AT yinqinqin afixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity
AT zhangyujun afixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity
AT lvrong afixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity
AT gongdeying afixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity
AT kebowen afixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity
AT yangjun afixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity
AT tanglei afixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity
AT zhangwensheng afixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity
AT zhutao afixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity
AT yinqinqin fixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity
AT zhangyujun fixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity
AT lvrong fixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity
AT gongdeying fixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity
AT kebowen fixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity
AT yangjun fixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity
AT tanglei fixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity
AT zhangwensheng fixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity
AT zhutao fixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity